Exodus Point Capital Management, LP Aura Biosciences, Inc. Transaction History
Exodus Point Capital Management, LP
- $11.4 Billion
- Q2 2025
A detailed history of Exodus Point Capital Management, LP transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 43,550 shares of AURA stock, worth $302,237. This represents 0.0% of its overall portfolio holdings.
Number of Shares
43,550Holding current value
$302,237% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AURA
# of Institutions
103Shares Held
51.4MCall Options Held
0Put Options Held
0-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$48 Million22.54% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA5.1MShares$35.4 Million1.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$33.9 Million0.05% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR4.62MShares$32.1 Million1.33% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.37MShares$30.3 Million0.94% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $203M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...